Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $19.54B.
ENTERPRISE VALUE (EV)
$19.54B
United Therapeutics Corporation
Market Cap
$21.10B
Enterprise Value (EV)
$19.54B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| United Therapeutics Corporation (UTHR) | $21.10B | $19.54B |
| STERIS plc (STE)vs › | $20.54B | $22.10B |
| Viatris Inc. (VTRS)vs › | $19.23B | $31.97B |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.09B | $25.16B |
| BioNTech SE (BNTX)vs › | $24.30B | $13.54B |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.37B | $24.24B |
| Incyte Corporation (INCY)vs › | $24.62B | $20.68B |
| Labcorp Holdings Inc. (LH)vs › | $25.55B | $32.17B |
| Medpace Holdings, Inc. (MEDP)vs › | $16.40B | $16.02B |
| Quest Diagnostics Incorporated (DGX)vs › | $25.94B | $31.70B |
Market Cap
$21.10B
Total Debt
$0.00
Cash
$1.56B
Enterprise Value
$19.54B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
